Cognizant plans to employ its Neuro AI generative AI platform to assist Gilead in enhancing IT and business processes, with the intent to create value and transform the user experience of IT services.

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to unlock even greater value for Gilead as it advances ...

TEANECK, N.J., Jan. 30, 2025 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ ...

Cognizant recently announced its collaboration with Gilead Sciences to expand their partnership. They will leverage machine learning, generative AI, and advanced technology solutions to enhance ...